In this video, Edward Stadtmauer, MD, Section Chief for Hematologic Malignancies at the Abramson Cancer Center, examines the current state of affairs for patients with newly diagnosed multiple myeloma, offers strategies for the ideal initial treatment regimen, and reviews the safety and efficacy outcomes from clinical trials for new combinations of familiar agents now being used in combination with standard of care autologous stem cell transplantation.
Related Links
Published
May 12, 2016
Created by
BROADCASTMED